Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gregor Diagnostics
Madison, Wisconsin, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Gregor Diagnostics is developing a novel, non-invasive prostate cancer screening test using seminal fluid, aiming to detect cancer at early stages and distinguish between indolent and aggressive forms to reduce overdiagnosis and overtreatment[1][3][4]. The company has published initial findings and is planning a second study, with future steps including an FDA Pivotal Trial for asymptomatic patients[4].
- Therapeutic areas
- Oncology
- Modalities
- Molecular diagnostic assay
- Industry
- Molecular Diagnostics
02
Partnerships
Wisconsin Alumni Research Foundation (WARF)Forward BIOLABS
Beyond the preview
Go deeper on Gregor Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gregor Diagnostics.